Goker E - Search Results

1

Molecular mechanisms of resistance to antifolates, a review.

Banerjee D, Ercikan-Abali E, Waltham M, Schnieders B, Hochhauser D, Li WW, Fan J, Gorlick R, Goker E, Bertino JR. Banerjee D, et al. Among authors: goker e. Acta Biochim Pol. 1995;42(4):457-64. Acta Biochim Pol. 1995. PMID: 8852336 Review.

2

Enzymes of the thymidylate cycle as targets for chemotherapeutic agents: mechanisms of resistance.

Bertino JR, Li WW, Lin J, Trippett T, Goker E, Schweitzer B, Banerjee D. Bertino JR, et al. Among authors: goker e. Mt Sinai J Med. 1992 Oct;59(5):391-5. Mt Sinai J Med. 1992. PMID: 1435833 Review.

3

Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations.

Göker E, Waltham M, Kheradpour A, Trippett T, Mazumdar M, Elisseyeff Y, Schnieders B, Steinherz P, Tan C, Berman E, et al. Göker E, et al. Blood. 1995 Jul 15;86(2):677-84. Blood. 1995. PMID: 7605998 Free article.

4

Drug resistance in acute leukemia.

Bertino JR, Göker E. Bertino JR, et al. Among authors: goker e. Leuk Lymphoma. 1993;11 Suppl 2:37-41. doi: 10.3109/10428199309064260. Leuk Lymphoma. 1993. PMID: 8124231 Review. No abstract available.

5

Intrinsic and acquired resistance to methotrexate in acute leukemia.

Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR. Gorlick R, et al. Among authors: goker e. N Engl J Med. 1996 Oct 3;335(14):1041-8. doi: 10.1056/NEJM199610033351408. N Engl J Med. 1996. PMID: 8793930 Review. No abstract available.

6

Resistance mechanisms to methotrexate in tumors.

Bertino JR, Göker E, Gorlick R, Li WW, Banerjee D. Bertino JR, et al. Among authors: goker e. Stem Cells. 1996 Jan;14(1):5-9. doi: 10.1002/stem.140005. Stem Cells. 1996. PMID: 8820944 Review.

7

Resistance Mechanisms to Methotrexate in Tumors.

Bertino JR, Göker E, Gorlick R, Li WW, Banerjee D. Bertino JR, et al. Among authors: goker e. Oncologist. 1996;1(4):223-226. Oncologist. 1996. PMID: 10387992

8

Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate.

Göker E, Kheradpour A, Waltham M, Banerjee D, Tong WP, Elisseyeff Y, Bertino JR. Göker E, et al. Leukemia. 1995 Feb;9(2):274-6. Leukemia. 1995. PMID: 7532768

9

Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease.

Göker E, Lin JT, Trippett T, Elisseyeff Y, Tong WP, Niedzwiecki D, Tan C, Steinherz P, Schweitzer BI, Bertino JR. Göker E, et al. Leukemia. 1993 Jul;7(7):1000-4. Leukemia. 1993. PMID: 7686600

10

Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection.

Lacerda JF, Göker E, Kheradpour A, Dennig D, Elisseyeff Y, Jagiello C, O'Reilly RJ, Bertino JR. Lacerda JF, et al. Among authors: goker e. Blood. 1995 May 15;85(10):2675-9. Blood. 1995. PMID: 7742525 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters